Targeting RNA to treat neuromuscular disease.
The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...
主要な著者: | Muntoni, F, Wood, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
類似資料
-
RNA-targeted splice-correction therapy for neuromuscular disease.
著者:: Wood, M, 等
出版事項: (2010) -
Syncoilin upregulation in muscle of patients with neuromuscular disease.
著者:: Brown, S, 等
出版事項: (2005) -
Splicing therapy for neuromuscular disease.
著者:: Douglas, A, 等
出版事項: (2013) -
Syncoilin expression in neuromuscular disorders
著者:: Torelli, S, 等
出版事項: (2001) -
Syncoilin expression in neuromuscular disorders.
著者:: Howman, E, 等
出版事項: (2001)